Hepatic Arterial Infusion Chemotherapy Clinical Trials in Shenyang, Liaoning

HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC